Ultrasound light added to usual care for infected diabetic foot ulcers
Part of Heart & circulation, Hormones & metabolism, Skin clinical trials.
This trial tests whether adding the VULNOFAST Plus/VULNOLIGHT system to usual care can heal infected diabetic foot ulcers more safely and effectively. It compares the added treatment plus usual care versus usual care alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able and willing to sign consent before any study checks or tests.
- You’re 18 or older and have either type 1 or type 2 diabetes.
- Your recent blood sugar levels (HbA1c) must be 10% or less, and fasting glucose must be under 300 mg/dl.
- You have an infected diabetic foot ulcer below the ankle that is between 2 and 40 square centimeters (and no longer than 10 cm across).
- The ulcer must be both deep enough and infected enough based on the PEDIS categories, but it must not reach the bone.
- You must be able to take pills by mouth, follow the study plan, and avoid certain recent antibiotics and procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new gel (Nu-3) to treat mild infections in diabetic foot ulcers. If you have diabetes and a small, shallow ulcer on or below your ankle with signs of infection, this treatment might help heal it without needing stronger medications.
This trial compares several advanced wound treatments (called CAMPs) plus standard care versus standard care alone for diabetic foot ulcers that are slow to heal. The goal is to see if adding these treatments helps ulcers close faster.
This trial tests whether adding a special treatment (cellular acellular and matrix-like products) to standard wound care helps diabetic foot ulcers and venous leg ulcers heal faster. It may be an option if you have a diabetes-related foot ulcer that hasn't healed with standard care.
This study tests whether a new wound gel helps heal diabetic foot ulcers better than the standard gel. It is for people with mild to moderate foot ulcers who have good blood flow and are not taking certain medications.
This trial tests a new treatment for foot ulcers caused by poor blood flow and diabetes. It compares the new treatment to a placebo (an inactive substance) to see if it helps ulcers heal better.
This trial tests if adding a special placenta-based wound covering to standard care helps heal diabetic foot ulcers and venous leg ulcers faster. It's for people with wounds that haven't healed after standard treatment for at least 4 weeks.
Hear when a new Diabetic Foot Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.